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PURPOSE: Characterization of the structural changes occurring in the pulmonary arteries resulting from surgically produced
congenital diaphragmatic hernia in rabbits, with particular emphasis on the preventive effects of prenatal tracheal ligation or
administration of intra-amniotic dexamethasone or surfactant.
METHODS: Twenty rabbit fetuses underwent surgical creation of a left-sided congenital diaphragmatic hernia on the 24th or
25th gestational day. They were divided according to the following procedures: congenital diaphragmatic hernia (n = 5), congenital
diaphragmatic hernia plus tracheal ligation (n = 5), congenital diaphragmatic hernia plus intra-amniotic administration of
dexamethasone 0.4 mg (n = 5) or surfactant (Curosurf 40 mg, n = 5). On gestational day 30, all the fetuses were delivered by
caesarean section and killed. A control group consisted of five nonoperated fetuses. Histomorphometric analysis of medial thickness,
cell nuclei density, and elastic fiber density of pulmonary arterial walls was performed.
RESULTS: Arteries with an external diameter > 100 m have a decreased medial thickness, lower cell nuclei density, and
greater elastic fiber density when compared with arteries with external diameter  100 m. Congenital diaphragmatic hernia promoted
a significant decrease in medial thickness and an increase in cell nuclei density in artery walls with external diameter > 100 m.
Prenatal treatments with tracheal ligation or intra-amniotic administration of dexamethasone or surfactant prevented these changes.
In arteries with external diameter  100 m, congenital diaphragmatic hernia promoted a significant increase in medial thickness
and in cell nuclei density and a decrease in elastic fiber density. The prenatal treatments with tracheal ligation or intra-amniotic
administration of dexamethasone or surfactant prevented these changes, although no effect was observed in elastic fiber density in
the congenital diaphragmatic hernia plus dexamethasone group.
CONCLUSIONS: Congenital diaphragmatic hernia promoted different structural changes for large or small arteries. The
prenatal intra-amniotic administration of dexamethasone or surfactant had positive effects on the lung structural changes promoted
by congenital diaphragmatic hernia, and these effects were comparable to the changes induced by tracheal ligation.
DESCRIPTORS: Congenital diaphragmatic hernia. Persistent pulmonary hypertension. Pulmonary hypoplasia.
Surfactant. Glucocorticoid.
Patients with congenital diaphrag-
matic hernia (CDH) have a high mor-
tality rate, which has been attributed to
pulmonary hypoplasia, pulmonary hy-
pertension, and biochemical and struc-
tural immaturity of the lungs1-4. We
have previously shown that fetal tra-
cheal ligation (TL) reverses pulmonary
hypoplasia in a rabbit model of CDH
by accelerating fetal alveolar growth.
In the same series of experiments, we
also demonstrated that prenatal intra-
amniotic administration of surfactant
or corticosteroids partially reverses the
pulmonary hypoplasia of fetuses with
CDH5.
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Clinical and animal studies have shown
that lungs with CDH are less compliant
than normal lungs6,7. This low compliance
is attributable to a higher surface tension
caused by surfactant deficiency and abnor-
mal stiffness of lung parenchyma, which
may be caused by an increased concentra-
tion of collagen and decreased density of
elastic fibers5,8. Hedrick et al.9 demonstrated
that prenatal glucocorticoid therapy im-
proves pulmonary maturity parameters in
rodent and sheep models of CDH. Taira et
al.10 reported that the administration of
glucocorticoids has no effect on pulmonary
tropoelastin and procollagen expression in
lungs with CDH. However, in a previous
study of lung glycogen content, elastic fiber
density, and collagen content, we verified
that the effects of prenatal intra-amniotic
administration of surfactant or dexametha-
sone are comparable to changes induced by
TL; therefore, these drug therapies may be
substitutes for TL8.
The pulmonary vascular abnormali-
ties that have been implicated in pulmo-
nary hypertension in CDH are a decrease
in the number of pulmonary arteries per
unit lung volume, an increase in the me-
dial thickness, and primarily the
muscularization of small arteries11. Fur-
thermore, some authors have recently re-
ported that in addition to the changes in
the medial thickness of small pulmonary
arteries, increased adventitial thickness is
also a consistent feature. These structural
changes may result from an increase in
intramural pressure12-14.
The purpose of the current study was
to investigate the structural changes in the
pulmonary arteries of surgically created
diaphragmatic hernia in rabbits and the
preventive effects of prenatal TL or intra-
amniotic administration of dexamethasone
or surfactant on these alterations.
MATERIALS AND METHODS
Experimental Animals
Twenty-five fetuses from 25 preg-
nant New Zealand rabbits were distrib-
uted into 5 groups. For the experimen-
tal groups, 20 fetuses underwent surgi-
cal creation of a left-sided CDH on the
24th or 25th gestational day as previ-
ously described5,8,15 (the normal full ges-
tation time is 31 days). They were di-
vided according to the following proce-
dures: CDH (n = 5), CDH plus TL (n =
5), CDH plus intra-amniotic administra-
tion of a single dose of dexamethasone
(0.4 mg, n = 5) and CDH plus intra-am-
niotic administration of surfactant (40
mg of Curosurf, Pharmalab-Chiesi, São
Paulo, Brazil, n = 5). After the surgical
manipulations, each one received 400
mg of cephalothin intravenously and 5
mg of Depo-Provera® (NV, Upjohn,
Belgium) intramuscularly.
On gestational day 30, all the fe-
tuses were delivered by cesarean sec-
tion and killed by intraperitoneal injec-
tion of thiobarbiturate. A control group
consisted of 5 nonoperated fetuses.
Tissue
Lung tissue specimens were ob-
tained from the central region of the
lower lobe of the left lung of each ani-
mal. The lungs were previously perfu-
sed through the trachea with buffered
formalin solution (6%) at a pressure of
20 cm of H2O for 2 hours and immersed
in the same formalin solution. The lung
samples were embedded in historesin
embedding medium (Leica) and sec-
tioned at a setting of 1 m on a micro-
tome (Leica RM 2035). The slides were
stained for 10 minutes in a Meyer
hematoxylin stain and for 1 hour in a
resorcin-fuchsin (Weigert) stain for the
nuclei and elastic fibers respectively.
Morphometric Assessment of Pulmo-
nary Arteries
To determine whether the charac-
teristic structural changes were size-re-
lated, arteries were grouped according
to Brenner16: (i) external diameter (ED)
> 100 m (the muscular arteries or pre-
acinar arteries that accompany con-
ducting airways); (ii) ED  100 m
(the arterioles or intra-acinar arterioles
associated with the respiratory bronchi
and saccules).
Morphometric measurements were
performed with an optical electronic
image analysis system (Kontron 300,
UK). A blinded investigator then stud-
ied lung sections from 5 fetuses in each
of the 5 groups. The transversely sec-
tioned pulmonary arteries present in
the tissue were examined to measure
the following parameters: external di-
ameter (ED), the diameter between the
external elastic lamina; internal diam-
eter (ID), the diameter between the in-
ternal elastic lamina; elastic fiber den-
sity in the arterial wall (EF), expressed
as a fraction of the area; and cell nu-
clei density in the arterial wall (CD),
expressed as cell nuclei/µm2. The me-
dial wall thickness (MT) was calcu-
lated as half the difference between the
mean ED and ID, divided by ED, ac-
cording to Best and Heath17. Therefore,
MT was expressed as a percentage of
the external diameter of the vessel to
nullify the effects of vasodilatation or
vasoconstriction on the measurements,
as previously discussed18. Large arter-
ies were measured on the monitor from
the microscope image with x20 or x40
objectives, and the smaller ones were
measured with a x100 objective.
Statistical Analysis
The morphometric values were cal-
culated from the groups and expressed
as mean ± standard desviation (SD), for
each variable. All comparisons were
performed using the analysis of variance
(ANOVA) for parametric data or the
ANOVA on Ranks and Dunn’s method
for multiple comparison procedure for
non-parametric data. Analyses were per-
formed with the SigmaStat 2.0 software
package (Jandel Scientific). Significant
results were obtained for P < .05.
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RESULTS
In all groups, pulmonary arteries
with ED > 100 m exhibited an evident
internal elastic laminae with some oth-
ers exhibiting elastic laminae in the
medial wall (Fig. 1). Arteries with ED
 100 m exhibited evident internal
elastic laminae and some elastic fibers
in the medial wall that may or may not
constitute an elastic lamina. The small
ones showed some elastic fibers in
their medial wall (Fig. 2). Between
these elastic laminae or fibers, we
could see the nuclei of the smooth
muscle cells arranged in concentric
layers (Fig. 3).
The data from the morphometric
analyses of pulmonary arteries with ED
> 100 m and ED  100 m are ex-
pressed in tables 1 and 2 and in figs. 4
to 6.
In all groups, the comparisons of
the parameters for arteries with ED >
100 m and arteries with ED  100 m
showed significant differences (P <
.05). The muscular arteries (ED > 100
m) revealed lower MT and lower CD,
but greater EF (P < .05).
The comparison of the parameters
of the arteries with ED > 100 m be-
tween control and experimental groups
showed that the CDH promoted a sig-
nificant decrease (P < .05) in MT. Con-
sidering the number of cell nuclei per
square micrometer, we found that CDH
promoted an increase in the cell den-
sity, in comparison to control animals.
This change may be due to a decrease
of the medial surface area of these ar-
teries in the CDH lungs. The prenatal
treatments with TL or intra-amniotic
administration of dexamethasone or
surfactant prevented these changes.
There was no difference between
the control and experimental groups in
EF in the walls of the pulmonary arter-
ies with ED > 100 m, although a non-
significant decrease was observed in
the CDH group.
The comparison between control
and experimental groups showed that
CDH promoted a significant increase
(P < .05) in MT of the arteries with ED
 100 m. We found that CDH pro-
moted an increase in CD in compari-
son to that found in the control ani-
mals. This change may provide an ex-
planation for the increased MT of these
vessels. The prenatal treatments with
TL or intra-amniotic administration of
surfactant or dexamethasone prevented
these changes.
CDH induced a decrease in EF in
arteries with ED  100 m. There was
no production of elastic fibers with the
increased number of cells. The prenatal
treatments with TL or administration of
surfactant prevented this change, al-
though no effect was observed in the
CDH plus dexamethasone group.
Figure 2 - Micrograph of a small pulmonary artery (ED  100 m) showing some elastic fibers
(arrowhead) in the medial wall (Weigert-hematoxylin, x2000).
Figure 1 - Micrograph of a pulmonary artery with ED > 100 µm showing an internal elastic laminae
(arrowhead) with some other elastic laminae in the medial wall (Weigert-hematoxylin, x400).
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DISCUSSION
Experimental model: We chose
the rabbit model of CDH because it
was previously standardized in our
laboratory and shown to produce pul-
monary hypoplasia8,15. In the current
study, we aimed to study whether pre-
natal therapeutic procedures could pre-
vent the structural changes in the pul-
monary arteries induced by surgically
created CDH. To date, the only method
that effectively treats or prevents all the
changes of the herniated viscera on the
developing lung in CDH fetus is tra-
cheal occlusion, an invasive procedure.
In 2 previous investigations, we pro-
posed a new noninvasive therapeutic
strategy, which consisted of prenatal
intra-amniotic administration of high
doses of swine surfactant (40 mg) or
dexamethasone (0.4 mg), and we have
proved that these treatments have posi-
tive effects on the immature lung of the
fetal rabbit with CDH5,8, although we
could not explain the mechanisms by
which the intra-amniotic administered
drugs produce their effects.
We chose the intra-amniotic route
for administering the surfactant sub-
stance in the prenatal period to prevent
pulmonary hypoplasia, since most in-
vestigations have used surfactant
therapy prophylactically, i.e., before
the onset of ventilation19. It has been
suggested that when exogenous sur-
factant is considered for the newborn
Table 1 - Values of morphometric data of arteries with external diameter > 100 µm.
Control Congenital Congenital Congenital Congenital
diaphragmatic diaphragmatic hernia diaphragmatic diaphragmatic
hernia + Tracheal ligation hernia+Dexa hernia+Surf
External diameter(mean±SD) 243.4±160.13 181.5±65.41 170.7±65.58 213.4±78.22 183.9±75.45
Internal diameter(mean±SD) 155.3±98.46 136.3±54.75 117.1±47.15 156.2±63.67 127.7±58.59
Table 2 - Values of morphometric data of arteries with external diameter  100 µm.
Control Congenital Congenital Congenital Congenital
diaphragmatic diaphragmatic hernia diaphragmatic diaphragmatic
hernia + Tracheal ligation hernia+Dexa hernia+Surf
External diameter(mean±SD) 64.6±18.93 44.5±20.66 52.7±19.61 51.1±18.04 57.1±21.77
Internal diameter(mean±SD) 37.6±11.76 22.8±19.21 27.7±16.88 27.5±15.71 32.5±18.65
Figure 4 - Medial thickness (MT) of pulmonary arteries. (*) P < .05 – The comparisons between
arteries with external diameter (ED) > 100 m and ED  100 m demonstrate that the muscular
arteries (ED > 100 m) have a decreased MT; (#) P < .05 - relative to the control group. All the
therapeutic procedures prevented the changes induced by congenital diaphragmatic hernia. The type
of error bar (SD) should be noted.
Figure 3 - Micrograph of medial wall of a pulmonary artery showing nuclei profiles (arrowheads) of
the smooth muscle cells arranged in concentrical layers between the elastic laminae (Weigert-
hematoxylin, x2000).
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with CDH, it should be administered as
early as possible, preferably before the
infant’s first breath20. Concerning the
route of antenatal administration of
glucocorticoids, we also chose the in-
tra-amniotic one because we had pre-
viously noted that the intramuscular
injection of dexamethasone into the
pregnant does had a significant labor-
inducing effect, causing a high inci-
dence of spontaneous abortion.
The respiratory movements of the
fetus with inflow of the amniotic fluid
begin early in pregnancy, and in addi-
tion to being a normal function of the
fetus, play an important role in the de-
velopment of the lungs21. Although
many previous studies suggest that the
fetal lungs produce a fluid that flows
constantly from the lungs to the amni-
otic cavity22,23, there is some evidence
that drugs infused into the amniotic cav-
ity may be aspirated by the fetus. In ex-
periments of transamniotic fetal feeding
using a rabbit model and lipid emulsion
as the nutrient, it was observed that the
fetal alveoli were filled with lipid glob-
ules, which proved that amniotic fluid
is chronically aspirated by the fetus24. In
addition, in a previous similar investiga-
tion, we infused a mixture of porcine
surfactant with microparticles of coal
into the amniotic cavities of fetuses with
CDH and of nonoperated littermates,
and we noted that in all fetuses, the coal
was massively aspirated into the lungs
and trachea8.
It has been shown that CDH pro-
motes alveolar hypoplasia, decreases
the total size of the pulmonary vascu-
lar bed and the number of vessels per
unit area of lung, and increases the
muscularization of the arterial tree11,25-
27
. Levin28 demonstrated that there is
increased medial width and smooth
muscle in resistance vessels in all lungs
of patients with left-sided CDH and al-
veolar hypoplasia. Recently, Shehata et
al.12 showed that raised levels of vas-
cular endothelial growth factor occur in
the medial smooth muscle cells of large
and small pulmonary arteries in pa-
tients with CDH.
In the present study, we demon-
strated morphometric changes of the
components of pulmonary arteries in
rabbits with CDH, and we verified a
reversal of these changes with prena-
tal fetal treatments, utilizing TL or in-
tra-amniotic administration of dexam-
ethasone or surfactant. Emphasis was
given here on the quantitative mor-
phological differences between large
and small arteries in control and ex-
perimental animals.
Morphometric measurements –
medial wall thickness (MT): In previ-
ous experiments, some authors reported
that the hypoplasia of both large and
capillary pulmonary vessels is related to
a muscularization of pulmonary arterial
vessels in animals with CDH. They re-
ported that fetal TL is capable of revers-
ing these effects by accelerating both
large vessel growth and capillary growth
based on total large vessel area and to-
tal capillary number1,28. The TL treat-
Figure 5 - Density of cell nuclei (CD) in the pulmonary arterial wall. (*) P < .05 – The comparisons
between arteries with external diameter (ED) > 100 m and ED  100 m demonstrate that the
muscular arteries (ED > 100 m) have fewer cell nuclei per square micrometer; (#) P < .05 – relative
to the control group. All the therapeutic procedures prevented the changes induced by CDH.
Figure 6 - Elastic fiber density (EF) (fraction of the pulmonary arterial wall area). (*) P < .05 – The
comparison between arteries with external diameter (ED) > 100 m and ED  100 m; (#) P < .05 –
relative to the control group. There was no difference between the control and experimental groups
in the arteries with ED > 100 m. The therapeutic procedures, TL, and prenatal intra-amniotic surfactant
administration prevented the change induced by CDH in the arteries with ED  100 m.
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ment also appears to accelerate the lung
maturation process19.
We also demonstrated that in the
muscular pulmonary arteries with ED
> 100 m, CDH promoted a decreased
MT, probably as a result of a vasodila-
tation phenomenon, similar to what
occurs in patients with atrial septal de-
fect and other congenital heart diseases
characterized by the presence of high
pulmonary blood flow over a pro-
longed period prior to the onset of pul-
monary hypertension. A dilatation oc-
curs in pulmonary vessels with a thin-
ning of the media as an expression of
the compensation to severe pulmonary
resistance29.
Elastic fiber density and cell nu-
clei density in the pulmonary arterial
wall: By definition, elastic arteries are
those with one or more elastic laminae
between internal and external elastic
laminae, whereas the muscular arteries
have only the internal and external
elastic laminae16,30. In our study, the
pulmonary arteries with ED > 100 m
were characterized as muscular arter-
ies and exhibited one or more addi-
tional elastic laminae between the in-
ternal and external elastic laminae. In
contrast, the smaller arteries with ED
 100 m had only a crescent of
smooth muscle, and the internal elas-
tic laminae disappeared, with some
elastic fibers being observed between
the muscle cells. This phenomenon
may be caused by a reduced capacity
for response to the physiological ac-
tions of contraction or dilatation, since
we have demonstrated that these small
vessels have a greater density of cell
nuclei than do the muscular arteries
with ED > 100 m. We suggest that the
large arteries control the blood flow,
while the small ones are responsible
for the resistance of the flow.
The walls of the arteries with ED
 100 m are thicker and have more
cells per unit area than the muscular ar-
teries with ED > 100 µm, and this find-
ing agrees with those of previous stud-
ies1,25,28. The small arteries also have a
lower tensile strength and thus can
stretch farther to accommodate the
higher interior pressure. The presence of
abnormally thick-walled pulmonary ar-
teries in stillborns with CDH suggests
that the intrapulmonary arteries in CDH
may become excessively muscularized
during fetal life, becoming unable to
adapt normally at birth31.
A previous investigation reported
that some prenatal treatments improve
these structural changes in the pulmo-
nary arteries promoted by CDH. Lipsett
et al.32 demonstrated that tracheal occlu-
sion performed in the lamb model of
CDH stimulates lung development and
restores lung structure and maturity to-
wards normal levels by gestational term.
There was also an increased volume
density of parenchyma, airspace, and
gas-exchange surface. Okoye et al.11
studied the effect of prenatal gluco-
corticoids on pulmonary vascular mus-
cularization in experimental CDH. They
verified an increased MT ratio of pre-
acinar and intra-acinar arteries in CDH
and demonstrated that maternal admin-
istration of dexamethasone inhibits this
medial hypertrophy. The same observa-
tion was made in rats with nitrofen-in-
duced CDH33. However, Shehata et al.12
showed that treatment with extracorpor-
eal membrane oxygenation (ECMO)
did not improve this increase in arterial
medial thickness in newborns with
CDH. The ECMO-treated newborns
with CDH showed a thinner arterial ad-
ventitia than did patients with CDH who
did not receive this treatment.
We observed that there is an in-
crease in cell density and a decrease in
the density of elastic fibers in small
pulmonary arteries of animals with
CDH. The prenatal treatments with TL
or administration of surfactant or dex-
amethasone are capable of preventing
the structural changes in arteries of all
sizes, except that the administration of
dexamethasone does not prevent any
loss of elastic fibers in small pulmo-
nary arteries. This last change may re-
sult in a less compliant arterial wall
better suited to resisting the higher in-
tra-arterial pressure. Yamataka and Puri
reported similar results13,14, which
showed an active synthesis of collagen
in the media and adventitia of pulmo-
nary arteries in patients with CDH
complicated by persistent pulmonary
hypertension.
In conclusion, the present study
demonstrates that animals with CDH
have different structural changes in
large and small pulmonary arteries,
confirming their diverse physiological
function. Furthermore, this is the third
study showing that prenatal intra-am-
niotic administration of dexamethasone
or surfactant has positive effects on the
lung structural changes promoted by
CDH, and that these effects are com-
parable to the changes induced by
TL. Further studies in lambs must be
undertaken to confirm these results be-
fore embarking in a clinical trial in hu-
mans.
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RESUMO RHCFAP/3061
RODRIGUES CJ e col. - Ligadura de
traquéia no período pré-natal ou
administração intra-amniótica de
surfactante ou dexametasona evi-
tam algumas alterações estruturais
nas artérias pulmonares de fetos de
coelho com hérnia diafragmática
congênita produzida com cirurgia.
Rev. Hosp. Clín. Fac. Med. S.
Paulo 57(1):1-8, 2002.
OBJETIVO: Caracterização das
alterações estruturais que ocorrem nas
artérias pulmonares de fetos de coelho
com hérnia diafragmática congênita
produzida com cirurgia, com destaque
especial aos efeitos preventivos da li-
gadura de traquéia ou administração
intra-amniótica de dexametasona ou
surfactante.
MÉTODOS: Vinte fetos de coelho
foram submetidos a cirurgia para pro-
dução de hérnia diafragmática no 24o ou
25o dia de gestação. Os animais foram
divididos de acordo com os procedi-
mentos: hérnia diafragmática congêni-
ta (n = 5), hérnia diafragmática congê-
nita com ligadura de traquéia (n = 5),
hérnia diafragmática congênita com
administração intraamniótica de 0,4mg
de dexametasona (n = 5) ou surfactante
(40mg de Curosurf, n = 5). No 30o dia
de gestação, todos os fetos foram reti-
rados por cesariana e mortos. O grupo
controle consistiu de 5 fetos normais
não operados. Foram realizadas análises
histomorfométricas da parede das arté-
rias pulmonares: espessura da camada
média, contagem do número de núcle-
os celulares e densidade de fibras elás-
ticas.
RESULTADOS: As artérias com
diâmetro externo > 100 m apresenta-
ram diminuição da espessura da cama-
da média, menor número de núcleos
celulares por micrômetro quadrado e
maior densidade de fibras elásticas em
comparação com as artérias com diâ-
metro externo diâmetro externo  100
m. A hérnia diafragmática congênita
provocou significativa redução na es-
pessura da camada média e aumento
do número de núcleos nas artérias com
diâmetro externo > 100 m. Os méto-
dos terapêuticos, ligadura de traquéia
e administração intraamniótica de dro-
gas promoveram reversão destas alte-
rações. Nas artérias com diâmetro ex-
terno  100m a hérnia diafragmática
congênita provocou aumento da espes-
sura da camada média e na contagem
de núcleos e decréscimo da densidade
de fibras elásticas. A ligadura de tra-
quéia e a administração intraamniótica
de surfactante ou dexametasona rever-
teram estas alterações embora esta úl-
tima não tenha tido efeito sobre a den-
sidade de fibras elásticas.
CONCLUSÃO: A hérnia diafrag-
mática congênita provoca diferentes al-
terações estruturais nas pequenas e
grandes artérias pulmonares. A admi-
nistração intraamniótica de surfactante
ou dexametasona tem efeitos positivos
nestas alterações estruturais, compará-
veis à ligadura de traquéia.
DESCRITORES: Hérnia diafrag-
mática congênita. Hipertensão pul-
monar persistente. Hipoplasia pul-
monar. Surfactante. Glicocorticóide.
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